Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

This study has been completed.
Sponsor:
Information provided by:
Baqiyatallah Medical Sciences University
ClinicalTrials.gov Identifier:
NCT00512811
First received: August 7, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted

August 7, 2007
August 7, 2007
Not Provided
Not Provided
effect of furosemid inhalation on dyspnea
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure

Not Provided
Interventional
Phase 3
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Bronchiolitis
Drug: furosemide
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion Criteria:

  • A contraindication for furosemide use;
  • An accompanying disease in which other drugs effective for dyspnea were used
Male
32 Years to 83 Years
Not Provided
Contact information is only displayed when the study is recruiting subjects
Iran, Islamic Republic of
 
NCT00512811
121a25
Yes
Not Provided
Baqiyatallah Medical Sciences University
Not Provided
Study Chair: Mostafa Ghanei, MD Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
Baqiyatallah Medical Sciences University
August 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP